Dr. Feng Zhang
Core Faculty Member, The Broad Institute
Feng Zhang is a molecular biologist focused on improving human health. He played an integral role in the development of two revolutionary technologies, optogenetics and CRISPR-Cas systems, including pioneering the use of Cas9 for genome editing and discovering CRISPR-Cas12 and Cas13 systems and developing them for therapeutic and diagnostics applications.
Zhang’s seminal work provided the foundation for CRISPR-based medicines, and his discoveries continue to fuel the clinical translation of CRISPR technologies. Additionally, he developed the diagnostic platform, SHERLOCK, which is being leveraged to help monitor infectious diseases, including the recent coronavirus outbreak.
Zhang is a core member of the Broad Institute, an Investigator at the McGovern Institute for Brain Research, the James and Patricia Poitras Professor of Neuroscience at MIT, and a Howard Hughes Medical Investigator. He is also a member of both the National Academy of Sciences and the American Academy of Arts and Sciences.